SCHRODER INVESTMENT MANAGEMENT GROUP - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 230 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,968,323
-29.5%
96,914
-11.0%
0.00%
-40.0%
Q3 2022$2,793,000
-30.1%
108,950
-32.5%
0.01%
-16.7%
Q2 2022$3,996,000
+26.2%
161,522
+23.4%
0.01%
+50.0%
Q1 2022$3,166,000
+15.4%
130,934
-5.5%
0.00%0.0%
Q4 2021$2,743,000
-2.9%
138,519
-3.5%
0.00%0.0%
Q3 2021$2,824,000
-17.5%
143,509
-7.7%
0.00%0.0%
Q2 2021$3,421,000
+19.5%
155,517
+29.3%
0.00%0.0%
Q1 2021$2,862,000
-79.0%
120,300
-76.9%
0.00%
-60.0%
Q4 2020$13,600,000
+379.2%
519,844
+209.9%
0.01%
+100.0%
Q3 2020$2,838,000
-4.6%
167,746
-5.2%
0.01%0.0%
Q2 2020$2,975,000
+25.6%
176,879
-13.8%
0.01%0.0%
Q1 2020$2,368,000
+996.3%
205,227
+1049.0%
0.01%
Q4 2019$216,000
-10.0%
17,862
+8.6%
0.00%
Q3 2019$240,000
-48.8%
16,453
-44.6%
0.00%
-100.0%
Q2 2018$469,000
-2.3%
29,680
+1.8%
0.00%0.0%
Q1 2018$480,000
-3.2%
29,153
+6.1%
0.00%0.0%
Q4 2017$496,000
+14.8%
27,488
+20.6%
0.00%0.0%
Q3 2017$432,000
+58.8%
22,8000.0%0.00%
Q2 2017$272,00022,8000.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,825,262$138,6217.54%
Novo Holdings A/S 3,377,768$68,602,4684.28%
Parallel Advisors, LLC 3,724,664$75,647,9263.28%
TANAKA CAPITAL MANAGEMENT INC 35,539$7222.29%
Quantedge Capital Pte Ltd 251,312$5,104,1471.71%
S&T BANK/PA 346,306$7,0331.30%
Freshford Capital Management, LLC 249,000$5,057,1901.09%
Birchview Capital, LP 50,000$1,0160.72%
FAS Wealth Partners, Inc. 306,276$6,220,4660.70%
Bridge City Capital, LLC 60,824$1,2350.63%
View complete list of CORCEPT THERAPEUTICS INC shareholders